Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature.
Open Forum Infect Dis. 2017;4(2):ofx040
Authors: Jacobs SE, Saez-Lacy D, Wynkoop W, Walsh TJ
Isavuconazole is a new triazole that is approved for primary therapy of invasive aspergillosis. We provide the first report of a patient with allergic bronchopulmonary aspergillosis (ABPA) who was successfully treated with isavuconazole with marked improvement and minimal adverse effects. We further review the literature on antifungal management of ABPA.
PMID: 28491888 [PubMed - in process]